Using Secondary Data to Evaluate Sex-based Heterogeneity of GLP-1 Agonists and SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic Health (CKMH) Outcomes in Real-world Settings (DASH-CKMH)

Name: Using Secondary Data to Evaluate Sex-based Heterogeneity of GLP-1 Agonists and SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic Health (CKMH) Outcomes in Real-world Settings (DASH-CKMH)
Published: 2025
License: Public Domain

Ohio State University · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

cardiovascular-disease

cardiovascular kidney metabolic syndrome, glp-1, sglt-2, ckms, ckmh, target trial, cardiovascular disease, observational

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Using Secondary Data to Evaluate Sex-based Heterogeneity of GLP-1 Agonists and SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic Health (CKMH) Outcomes in Real-world Settings (DASH-CKMH)

Related documents